Effect of Gh on pregnancy outcome in RIF

Evaluation the effect of growth hormone (Gh) on pregnancy outcome of recurrent implantation failure (RIF) via intrauterine infusion.

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20091012002576N34

Enrollment

Registered

2023-10-06

Start date

2023-10-12

Completion date

Unknown

Last updated

2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility. Female infertility of other origin

Interventions

Intervention 1: Intervention group: for thirthy patients, intracavitary growth hormone will be injected by IUI ?(Intrauterine Insemination) catheter one cm above internal OS cervix, 0.5 cc of Gh(Cinat

Eligibility

Sex/Gender

Female

Age

20 Years to 45 Years

Inclusion criteria

Inclusion criteria: History of recurrent implantation failure due to unknown etiology Having good quality mbryo

Exclusion criteria

Exclusion criteria: User of corticosteroids User of glucose control agents CNS tumors Uterine malformations Asherman syndrome Cavity distorting lesions Severe endometriosis Liver disease Severe male infertility Body mass index(BMI)>30 Uncontrolled hypothyroidism

Design outcomes

Primary

Measure	Time frame
Biochemical pregnancy. Timepoint: Two weeks after embryo transfer. Method of measurement: Beta HCG titer test (blood test).	—

Secondary

Measure	Time frame
Clinical pregnancy. Timepoint: Four weeks after embryo transfer. Method of measurement: Heart beat activity by transvaginal sonogram.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFatemeh Davari Tanha

Tehran University of Medical Sciences

Fatedavtanha@gmail.com+98 21 8880 0115

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026